| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193809 | Annals of Allergy, Asthma & Immunology | 2006 | 4 Pages |
Abstract
SLIT is a safe and effective therapeutic option for patients with allergic rhinitis and asthma. Because of its efficacy, safety, and ease of administration, it has been accepted in Europe, Southern Africa, Australasia, Southeast Asia, and the Middle East as a promising therapeutic option that can significantly alter the natural history of allergic disease without the risks of injection immunotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Paul C. MD, FCP(SA), DCH(SA),